Logo
x

Search

Subscribe Now

Project Orbis

AstraZeneca's Calquence (acalabrutinib) Receives the US FDA's Approval for Chronic Lymphocytic Leukemia Under the Project Orbis

AstraZeneca's Calquence (acalabrutinib) Receives the US FDA's Approval for Chronic Lymphocytic Leukemia Under the Project Orbis

  • November 22, 2019
PharmaShots Weekly Snapshot (September 16-20, 2019)

PharmaShots Weekly Snapshot (September 16-20, 2019)

  • September 23, 2019
The US FDA Initiates its First Step Towards Project Orbis for Concurrent Review of Cancer Therapies

The US FDA Initiates its First Step Towards Project Orbis for Concurrent Review of Cancer Therapies

  • September 18, 2019
Merck's Keytruda (pembrolizumab) + Eisai's Lenvima (lenvatinib) Receives FDA's Approval for Certain Types of Endometrial Carcinoma

Merck's Keytruda (pembrolizumab) + Eisai's Lenvima (lenvatinib) Receives FDA's Approval for Certain Types of Endometrial Carcinoma

  • September 18, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.